A Non-invasive Detection of Parkinson's Disease using PitArray: An Integrative Meta-Analysis and Machine Learning Approach
Arittra BhattacharjeeiD, Tabassum Binte JamaliD, Ishtiaque AhammadiD, Anika Bushra LamisaiD, Mohammad Shamsul ArefiniD, Zeshan Mahmud ChowdhuryiD, Mohammad Uzzal HossainiD, Keshob Chandra DasiD, Chaman Ara Keya, M. SalimullahiD
Abstract
Parkinsons disease (PD) is a progressive neurodegenerative disorder affecting the central nervous system, often diagnosed in its advanced stages due to the absence of sensitive biomarkers. With this objective in mind, our study conducted a comprehensive analysis of differentially expressed genes (DEGs) sourced from blood-based microarray datasets to uncover potential biomarkers and developed a machine learning based classifier to conduct two step validations. By analyzing gene expression of three projects, we identified 678 DEGs, consisting of 337 genes showing upregulation and 341 genes presenting downregulation. Additionally, insights from functional enrichment and the protein-protein network analysis indicate that HLA-F, IRF-1, and RPS28 have the potential to serve as biomarkers for diagnosing PD. Simultaneously, we employed feature selection techniques such as Least Absolute Shrinkage and Selection Operator with Cross Validation (LassoCV) followed by Recursive Feature Elimination with Cross Validation (REFCV) to filter our initial dataset of 13,249 genes down to 43 genes, which were subsequently used to train the machine learning-based classifier models. These 43 genes formed the basis for training and testing various machine learning models, including logistic regression, random forest, naive Bayes, k-nearest neighbors, support vector machine, and deep learning based artificial neural networks. Our models demonstrated robust performance, with Support Vector Machine outperforming others by 0.65 accuracy (95%CI: 0.58-0.66), 0.70 AUC-ROC (95%CI: 0.70-0.71) and 0.35 MCC (95%CI: 0.34-0.39). The model was implemented to develop the PitArray tool for non-invasive detection of PD from blood. PitArray is available at: https://github.com/Arittra95/PitArray. Key PointsO_LIHLA-F, IRF-1, and RPS28 were identified as potential biomarkers for Parkinsons disease diagnosis. C_LIO_LISeveral sophisticated feature selection methods recognized 43 genes which were then used to build a machine learning model. C_LIO_LIA Support Vector Machine based tool named PitArray was developed which could distinguish Parkinsons disease patients from healthy people based on blood transcriptome data. C_LI
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Application of Bayesian-Derived Gene Interaction Network and Subnetwork for Classification of Idiopathic Parkinson Disease with Biomarkers
R.T. Yang, Yaxia Yuan·bioRxiv·Oct 12, 2026
- Transcriptional pathobiology and multi-omics predictors for Parkinson's disease
Ruifeng Hu, Ruoxuan Wang, … Xianjun Dong·bioRxiv·Jun 18, 2024
- A Computational Approach in Identification of Putative Risk Genes in Parkinsons Disease
Bhargav Dave, Prasenjit Majumder, Shamayeeta Sarkar·bioRxiv·Oct 13, 2021
- Bioinformatics and next generation sequencing data analysis to identify key genes and pathways influencing in Parkinson's disease
Basavaraj Mallikarjunayya Vastrad, Chanabasayya Mallikarjunayya Vastrad·Genome Instability & DiseasePeer-reviewed·May 16, 2025
- Discovering Biomarker Proteins and Peptides for Parkinson's Disease Prognosis Prediction with Machine Learning and Interpretability Methods
Ho-min Park, Espoir K. Kabanga, … Wesley De Neve·bioRxiv·May 18, 2023
- Identification and Validation of N-Acetylputrescine in Combination With Non-Canonical Clinical Features As a Parkinsons Disease Biomarker Panel
Kuan‐Wei Peng, Allison Klotz, … Michael A. Kiebish·Scientific ReportsPeer-reviewed·May 1, 2024